Artificial Intelligence in Neurosurgery: Research and Responsible Innovation

Artificial intelligence is attracting growing interest in neurosurgery, from the analysis of brain images to the study of treatment outcomes. These applications offer opportunities for research and clinical support. Their value depends on evidence that a particular tool is reliable and useful in its intended setting.

Machine learning uses data to identify patterns and relationships. For neurosurgical research, a useful prediction must be evaluated in the context of the clinical question, the population studied, and the decisions it is intended to support.

Imaging and surgical planning

Researchers are evaluating tools that identify structures, outline tumors, and support the review of MRI and CT images. Performance needs to be assessed across scanners, institutions, and patient populations.

Simulations and predictive models can also help researchers compare planning approaches and study outcomes. Their outputs require clinical interpretation: a predicted outcome is not a guarantee for an individual patient.

Navigation, monitoring, and follow-up

Computational research explores ways to combine imaging, navigation, and monitoring information during surgery. The aim is to make relevant information easier to interpret while retaining the surgical team’s responsibility for decisions.

After treatment, predictive models are being studied for follow-up and the assessment of complications. Proposed alerts and risk estimates need evaluation before guiding care. Clinical context, patient preferences, and professional judgment remain central to individualized decisions.

The conditions for responsible use

Data quality is fundamental. Incomplete records, inconsistent definitions, and unrepresentative datasets can limit what a model learns and where its findings apply. Evaluation should extend beyond the data used to develop the system and make limitations visible to clinicians.

Research teams also need appropriate permissions and safeguards for the information they use, with clear communication about how it is handled. Shared data definitions and documented methods make studies easier to assess and reproduce.

Training matters throughout development and implementation. Clinicians need to understand a tool’s intended purpose and limitations, recognize unreliable outputs, and retain the expertise to work without it.

Looking ahead

AI-supported robotics, predictive alerts, and telemedicine remain areas of interest. Each application needs evidence for its intended use, including its effects on workflow, access, and patient outcomes.

Progress requires collaboration among clinicians, engineers, researchers, and ethicists. The priority is to develop and evaluate useful tools responsibly, with patient care as the measure of their value.